-
Medicare Spending on Orphan Drugs With Single and Multiple Rare Disease Indications
Mar 10, 2025, 14:00 PM -
Identifying Redundant or Misfitting Items Using Item Response Theory: Type I and II Error Rates for Item Local Dependence and Misfit Detection in Clinical Outcome Assessments
Mar 10, 2025, 14:00 PM -
Can Gen-AI Assist in Translating Health Economic Data Across Formats? A Proof-of-Concept for an HEOR Translator Tool
Mar 10, 2025, 14:00 PM -
Characteristics of Patients Enrolled in a Pharmacist Managed Rare Disease Program: Highlighting National Diversity and Representation
Mar 10, 2025, 14:00 PM -
Real-Time Technology Adoption: Assessing Early Real-World Trends in Renal Denervation Therapy Following Initial Device Approval
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Dostarlimab Plus Chemotherapy As First-Line Treatment for Metastatic Non-Squamous Non-Small Cell Lung Cancer in Japan
Mar 10, 2025, 14:00 PM -
Retrospective Real-World Study Assessing Treatment Patterns of Adult Patients with Moderate-to-Severe Psoriasis in the United States Initiating Advanced Therapies and Their Dispositions
Mar 10, 2025, 14:00 PM -
Identification of Barriers to and Practical Strategies for Increasing Clinical Trial Diversity: A Scoping Review
Mar 10, 2025, 14:00 PM -
Moving the Needle: Value and Use of Real-World Evidence in Oncology Clinical Pathways Decision-Making
Mar 10, 2025, 14:00 PM -
Estimates of the Public Health Impact of Norovirus Vaccination for Older Adults in the United States
Mar 10, 2025, 14:00 PM -
Trends in the Uptake of SGLT-2 Inhibitors in Type 2 Diabetes Mellitus With Comorbid Cardiovascular Conditions: A Longitudinal Analysis
Mar 10, 2025, 14:00 PM -
What is the Role of Humans in a World of Artificial Intelligence: An Exploratory Economic Evaluation of Human-AI Collaboration in Diabetic Retinopathy Screening
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis of Dupilumab Versus Omalizumab in the Treatment of Severe Asthma in China
Mar 10, 2025, 14:00 PM -
Real-World Study Evaluating Drug Tolerability and Health Care Resource Use (HCRU) With Acalabrutinib vs. Ibrutinib in Treatment-Naïve Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Mar 10, 2025, 14:00 PM -
Improving the Face Validity and Clinical Relevance of a Cancer Epidemiology Microsimulation Model Using a Novel Advisory Group Approach
Mar 10, 2025, 14:00 PM -
Validation of Artificial Intelligence (AI) Tool to Identify PICO Questions for EU Joint Clinical Assessment (JCA)
Mar 10, 2025, 14:00 PM -
Adoption of a Drug Adherence-Enhancing Application To Achieve Optimal Medication Adherence and Blood Pressure Control Among Hypertensive Patients: A Randomized Controlled Trial
Mar 10, 2025, 14:00 PM -
Informal Caregivers' Attitudes Towards Robots in Hungary and Poland
Mar 10, 2025, 14:00 PM -
Association Between Caregiver Quality of Life and the Care Provided to Adults With Severe Visual Impairments: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Focus Group Evaluation of Criteria for the Value Assessment of Medication-Adherence Enhancing Interventions (MAEIs)
Mar 10, 2025, 14:00 PM
